公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2017 | Erratum: Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer (Oncogene (2016) 35 18 (2357-2369)) | Jen J.; Lin L.-L.; Lo F.-Y.; Chen H.-T.; Liao S.-Y.; Tang Y.-A.; Su W.-C.; Salgia R.; CHIA-LANG HSU ; Huang H.-C.; Juan H.-F.; HSUEH-FEN JUAN et al. | Oncogene | 0 | 0 | |
2016 | Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer | Jen J.; Lin L.-L.; Chen H.-T.; Liao S.-Y.; Lo F.-Y.; Tang Y.-A.; Su W.-C.; Salgia R.; CHIA-LANG HSU ; Huang H.-C.; Juan H.-F.; Wang Y.-C. | Oncogene | 36 | 35 | |
2020 | Phase I dose-escalation and -expansion study of telisotuzumab (ABT-700), an Anti-c-met antibody, in patients with advanced solid tumors | Strickler J.H.; LoRusso P.; Salgia R.; Kang Y.-K.; Yen C.J.; CHIA-CHI LIN ; Ansell P.; Motwani M.; Wong S.; Yue H.; Wang L.; Reilly E.; Afar D.; Naumovski L.; Ramanathan R.K. | Molecular Cancer Therapeutics | 16 | 14 | |
2017 | A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer | Reynolds K.L.; Bedard P.L.; Lee S.-H.; Chia-Chi Lin ; Tabernero J.; Alsina M.; Cohen E.; Baselga J.; Blumenschein G.; Graham D.M.; Garrido-Laguna I.; Juric D.; Sharma S.; Salgia R.; Seroutou A.; Tian X.; Fernandez R.; Morozov A.; Sheng Q.; Ramkumar T.; Zubel A.; Bang Y.-J. | BMC Cancer | 22 | 21 |